In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA

Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA

(2021) Sabrina Klein et al.   CLINICAL INFECTIOUS DISEASES

Structural basis of reduced susceptibility to ceftazidime–avibactam and cefiderocol in Enterobacter cloacae due to AmpC R2 loop deletion

(2020) Akito Kawai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in Enterobacter cloacae complex following exposure to cefepime

(2020) Ryan K Shields et al.   CLINICAL INFECTIOUS DISEASES

Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3

(2020) Saquib Malik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

(2020) Naoki Kohira et al.   Journal of Global Antimicrobial Resistance

In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria

(2019) Yoshinori Yamano   CLINICAL INFECTIOUS DISEASES

Contribution of the colicin receptor CirA to biofilm formation, antibotic resistance, and pathogenicity of Salmonella Enteritidis

(2019) Zhiqiang Zhang et al.   JOURNAL OF BASIC MICROBIOLOGY

Klebsiella pneumoniae ST147 Coproducing NDM-7 Carbapenemase and RmtF 16S rRNA Methyltransferase in Minnesota

(2014) C.-S. Lee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

New Vector Tools with a Hygromycin Resistance Marker for Use with Opportunistic Pathogens

(2010) Eric J. Kalivoda et al.   MOLECULAR BIOTECHNOLOGY